Invitae Corporation DPO Ratio 2011-2026 | NVTA

Annual DPO Ratio Invitae Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
69	88	32.7	31.9	35.6	62.6	43.9	77.3	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
88	31.9	55.1

Quarterly DPO Ratio Invitae Corporation

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
26.8	18.2	13.3	-	14.6	28.3	29.5	26.8	34.7	35.9	38.8	33.7	49.3	53.5	40.1	25.6	29.3	33.6	38.9	33.7	34.9	34.9	41.4	46.1	59.2	74.9	58.5	-	42.2	47.2	52.2	-	80.8	82.6	90.7	-	155	271	214	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
271	13.3	56.9

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	125	$ 15.85	-2.49 %	$ 171 M	China
Aspira Women's Health AWH	189	-	-6.19 %	$ 10.5 M	USA
Agilent Technologies A	50.1	$ 115.06	-0.29 %	$ 35 B	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	149	$ 1.13	-2.59 %	$ 6.15 M	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	44.2	$ 16.05	-3.83 %	$ 855 M	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Interpace Biosciences IDXG	33	$ 2.3	-	$ 10.2 M	USA
Exact Sciences Corporation EXAS	49.2	-	-	$ 19.8 B	USA
Co-Diagnostics CODX	4.24 K	$ 4.4	101.83 %	$ 5.85 M	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	52	$ 23.13	-1.28 %	$ 642 M	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	24.5	$ 175.65	0.06 %	$ 8.71 B	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
Medpace Holdings MEDP	13.3	$ 493.53	-1.59 %	$ 14.2 B	USA
Danaher Corporation DHR	65.4	$ 189.61	-1.7 %	$ 135 B	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	56.3	$ 120.93	-2.22 %	$ 19.2 B	USA
Myriad Genetics MYGN	45.9	$ 4.35	-2.03 %	$ 403 M	USA
Fulgent Genetics FLGT	34.9	$ 14.43	-3.93 %	$ 436 M	USA
NeoGenomics NEO	19.7	$ 7.69	-3.17 %	$ 985 M	USA
Guardant Health GH	48.6	$ 78.6	-9.83 %	$ 9.85 B	USA
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	1.29 K	$ 2.69	-1.82 %	$ 87.3 K	USA
Biomerica BMRA	32.4	$ 2.13	-0.9 %	$ 4.89 M	USA
ICON Public Limited Company ICLR	6.52	$ 106.81	0.1 %	$ 8.81 B	Irlanda
Laboratory Corporation of America Holdings LH	31.5	$ 260.93	-4.51 %	$ 21.7 B	USA
Natera NTRA	17.9	$ 193.03	-4.91 %	$ 19 B	USA
Lantheus Holdings LNTH	23.6	$ 80.59	-1.03 %	$ 5.44 B	USA
Senseonics Holdings SENS	68	$ 6.68	0.15 %	$ 279 M	USA
Motus GI Holdings MOTS	1.72	-	-34.28 %	$ 263 K	Israel
Soleno Therapeutics SLNO	1.44 K	$ 52.63	0.23 %	$ 2.67 B	USA
Quest Diagnostics Incorporated DGX	14.7	$ 191.51	-3.19 %	$ 21.3 B	USA
Neogen Corporation NEOG	62.7	$ 9.42	-6.13 %	$ 2.04 B	USA
ENDRA Life Sciences NDRA	1.65 K	$ 4.94	-6.97 %	$ 3.89 M	USA
Neuronetics STIM	51.8	$ 1.35	-2.17 %	$ 89 M	USA
National Research Corporation NRC	10.1	$ 16.48	-3.34 %	$ 369 M	USA